C3S-26741-45845
2 vaccinations
2 coded responses
13 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 450 / OH
- Registered
- 2021-08-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-28
Dose 1 — Pfizer-BioNTech
-
2021-08-16
Registered in v-safe
- 2021-08-16
-
2021-08-18
Dose 2 — Pfizer-BioNTech
- 2021-08-20
- 2021-08-22
- 2021-08-24
- 2021-08-27
- 2021-09-01
- 2021-09-08
- 2021-09-17
- 2021-09-22
- 2021-10-01
- 2021-11-17
-
2022-02-16
Survey response — 6 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I contracted Covid January 19thMedDRA releases: 2024-11 · check-in free text available
-
2022-08-18
Survey response — 12 months, dose 2MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: I've had three summer colds. Have not tested positive for CovidMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-28 | Pfizer-BioNTech | No |
| 2 | 2021-08-18 | Pfizer-BioNTech | No |
Free text
Release 11 — 6 months, dose 2
Symptoms: I contracted Covid January 19th
Release 12 — 12 months, dose 2
Symptoms: I've had three summer colds. Have not tested positive for Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release